Literature DB >> 6277605

Apparent dissociation of adrenocorticotropin and corticosteroid responses to 15 ml/kg hemorrhage in conscious dogs.

C E Wood, J Shinsako, L C Keil, D J Ramsay, M F Dallman.   

Abstract

The blood pressure, heart rate, ACTH, corticosteroid, vasopressin, and renin responses to rapid 15 ml/kg hemorrhage were measured in six conscious healthy dogs with chronically maintained femoral arterial catheters. The hemorrhage decreased the mean arterial blood pressure slightly (P less than 0.001), increased the heart rate (P less than 0.001), and increased arterial plasma levels of ACTH (P less than 0.01), corticosteroids (P less than 0.001), vasopressin (P less than 0.001), and renin activity (P less than 0.001). Overall and in the individual experiments, there appeared to be little correspondence between the ACTH and corticosteroid responses. In none of the experiments was there a clear rise in ACTH above control levels before the first rise in corticosteroids. To ascertain that adrenal secretion of corticosteroids was increased during 15 ml/kg hypovolemia, changes in the clearance and distribution volume of cortisol were estimated by counting tritium extracted from plasma of five dogs infused with [1,2-3H] cortisol to steady state levels before and during hypovolemia. The stimulus caused a 30% reduction from steady state levels of dichloromethane-extractable tritium counts (P less than 0.001). Combined with the observed increase in plasma corticosteroid levels, these results show that the increase in adrenal secretion of corticosteroids after hemorrhage was underestimated by measurement of changes in peripheral plasma levels. The hypothesis that hemorrhage results in an increase in adrenal sensitivity to ACTH is tested in the following paper.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277605     DOI: 10.1210/endo-110-4-1416

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  The effect of changes in adrenal blood flow on adrenal cortical responses to adrenocorticotrophin in conscious calves.

Authors:  C T Jones; A V Edwards; S R Bloom
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

2.  Secretion of corticotrophin releasing factor from the adrenal during splanchnic nerve stimulation in conscious calves.

Authors:  A V Edwards; C T Jones
Journal:  J Physiol       Date:  1988-06       Impact factor: 5.182

3.  Dose response relationship between plasma ACTH and cortisol after the infusion of ACTH1-24.

Authors:  K R Krishnan; M N Miller; M J Helms; D Reed; J C Ritchie; C B Nemeroff; B J Carroll
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 4.  Autonomic control of adrenal function.

Authors:  A V Edwards; C T Jones
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

5.  Differential effects of transforming growth factor type beta on the growth and function of adrenocortical cells in vitro.

Authors:  M Hotta; A Baird
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  The effect of splanchnic nerve stimulation on adrenocortical activity in conscious calves.

Authors:  A V Edwards; C T Jones
Journal:  J Physiol       Date:  1987-01       Impact factor: 5.182

7.  The effect of splanchnic nerve section on the sensitivity of the adrenal cortex to adrenocorticotrophin in the calf.

Authors:  A V Edwards; C T Jones
Journal:  J Physiol       Date:  1987-09       Impact factor: 5.182

8.  Carotid sinus nerve section and the increase in plasma cortisol during acute hypoxia in fetal sheep.

Authors:  D A Giussani; H H McGarrigle; P J Moore; L Bennet; J A Spencer; M A Hanson
Journal:  J Physiol       Date:  1994-05-15       Impact factor: 5.182

9.  Feedback inhibition of adrenocorticotropic hormone by physiological increases in plasma corticosteroids in conscious dogs.

Authors:  M E Keller-Wood; J Shinsako; M F Dallman
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.